Constrictive Pericarditis After Pericardiocentesis

All interventional cardiologists must be able to perform a pericardiocentesis. Whether we deal with a chronic total occlusion, a supposedly simple coronary angioplasty (we all have witnessed the perforation of a supposedly risk-free coronary artery), or a transcatheter aortic valve replacement (whose rise gave us another significant source of tamponades), we must all be ready to face this problem.

El FFR ahorra síntomas a los pacientes y costos a los financiadores de saludWith common sense, we considered as good practice a “lavage” with saline solution after complete drainage of effusions, so as to reduce the likelihood of constrictive pericarditis. Our conduct was absolutely empirical, since we aimed to reduce the likelihood of a complication whose incidence we ignored.

This study included a large cohort of non-selected patients who underwent pericardiocentesis. Among them, 16% experienced constrictive pericarditis. The long-term prognosis of these patients was very good and pericardiectomy was rarely required.


Read also: Stroke, Migraine and Patent Foramen Ovale Not Necessarily Temporary Associated.


Constrictive pericarditis is characterized by the co-existence of tense effusion and constriction of the heart by the visceral pericardium.

A total of 205 consecutive patients undergoing pericardiocentesis at Mayo Clinic were divided into two groups based on the presence or absence of echocardiographic findings compatible with constrictive pericarditis after drainage.

Constrictive pericarditis was diagnosed in 33 patients (16%) after pericardiocentesis.


Read also: We Should Consider Mitral Stenosis Before TAVR.


Tamponade was clinically evident in and affected 52% of patients with constrictive pericarditis vs. 36% of those who did not present constrictive pericarditis (p = 0.08).

Hemopericardium was more frequent in patients with constrictive pericarditis (33% vs. 13%; p = 0,003). Certain echocardiographic findings, such as respiratory variation of mitral inflow velocity, expiratory diastolic flow reversal of hepatic vein, and respirophasic septal shift were predictors of constrictive pericarditis.

There were 4 deaths in the group of patients with constrictive pericarditis, although all of them had known history of malignancies at the time of diagnosis.

During a mean follow-up of 3.8 years (range: 0.5 to 8.3), only 2 patients required pericardiectomy for persistent constrictive symptoms.

Conclusion

In this large cohort of non-selected patients who required pericardiocentesis, 16% of subjects experienced constrictive pericarditis. The long-term prognosis for these patients is good and pericardiectomy is rarely required.

Original title: Effusive-Constrictive Pericarditis After Pericardiocentesis: Incidence, Associated Findings, and Natural History.

Reference: Kye Hun Kim et al. J Am Coll Cardiol Img 2018. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...